Gabapentin Capsule
Product Images NDC 82868-073

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 82868-073). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (82868 073 30 Rev A 03 25 Nhc)

This is a description of Gabapentin Capsules, USP containing 300mg in a pack of 30 capsules. The medication is prescription-only with storage instructions at 20° - 25°C (68 - 77°F). It is advised to keep it in the original container, tightly closed and away from children. For dosage information, refer to the package insert.*

FDA Label Image

Image (B7e57ea4 D985 4167 8c2d 716cf3c60114 01)

FDA Label Image

Image (B7e57ea4 D985 4167 8c2d 716cf3c60114 02)

FDA Label Image

Image (B7e57ea4 D985 4167 8c2d 716cf3c60114 03)

FDA Label Image

Image (B7e57ea4 D985 4167 8c2d 716cf3c60114 04)

This text provides data on the proportion of responders (patients with a 50% reduction in pain score) in controlled post-herpetic neuralgia (PHN) studies. The results from Study 1 show 32% of patients responded in the placebo group and 62% in the GBP 3600 group. In Study 2, 14% of patients responded in the placebo group and 62% in the GBP 1800 group and 42% in the GBP 2400 group. The statistical significance is indicated with p-values.*

FDA Label Image

Image (B7e57ea4 D985 4167 8c2d 716cf3c60114 05)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.